Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA152637-10
Application #
10135776
Study Section
Special Emphasis Panel (ZCA1)
Program Officer
Ghosh-Janjigian, Sharmistha
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
10
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Buas, Matthew F; Li, Christopher I; Anderson, Garnet L et al. (2018) Recommendation to use exact P-values in biomarker discovery research in place of approximate P-values. Cancer Epidemiol 56:83-89
Rho, Jung-Hyun; Ladd, Jon J; Li, Christopher I et al. (2018) Protein and glycomic plasma markers for early detection of adenoma and colon cancer. Gut 67:473-484
Garrison, Carly B; Lastwika, Kristin J; Zhang, Yuzheng et al. (2017) Proteomic Analysis, Immune Dysregulation, and Pathway Interconnections with Obesity. J Proteome Res 16:274-287
Böhm, Jürgen; Pianka, Frank; Stüttgen, Nina et al. (2017) Discovery of novel plasma proteins as biomarkers for the development of incisional hernias after midline incision in patients with colorectal cancer: The ColoCare study. Surgery 161:808-817
Zhao, Wei; Fitzgibbon, Matthew; Bergan, Lindsay et al. (2017) Identifying Abundant Immunotherapy and Other Targets in Solid Tumors: Integrating RNA-seq and Mass Spectrometry Proteomics Data Sets. Cancer J 23:108-114
Buas, Matthew F; Gu, Haiwei; Djukovic, Danijel et al. (2016) Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors. Gynecol Oncol 140:138-44
Urban, Nicole; Hawley, Sarah; Janes, Holly et al. (2015) Identifying post-menopausal women at elevated risk for epithelial ovarian cancer. Gynecol Oncol 139:253-60
Buas, Matthew F; Rho, Jung-hyun; Chai, Xiaoyu et al. (2015) Candidate early detection protein biomarkers for ER+/PR+ invasive ductal breast carcinoma identified using pre-clinical plasma from the WHI observational study. Breast Cancer Res Treat 153:445-54
Wu, Jing; Yin, Haidi; Zhu, Jianhui et al. (2015) Validation of LRG1 as a potential biomarker for detection of epithelial ovarian cancer by a blinded study. PLoS One 10:e0121112
Pepe, Margaret S; Li, Christopher I; Feng, Ziding (2015) Improving the quality of biomarker discovery research: the right samples and enough of them. Cancer Epidemiol Biomarkers Prev 24:944-50

Showing the most recent 10 out of 23 publications